BREAKING: Target Test Prep releases Brand New 2026 On Demand GMAT prep course

Redeem

Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

★★★★★5.0559 reviews
Vote for Target Test Prep, Newsweek Readers’ Choice Awards 2026
NEWSWEEK READERS’ CHOICE 2026

BIG NEWS! Target Test Prep has been nominated, and they’d love your vote!

TTP has worked incredibly hard to build the best test prep experience possible, and winning Newsweek’s 2026 Readers’ Choice Award for Best Test Prep would mean a lot to them. If TTP has helped you, they’d be incredibly grateful for your vote. You can vote once each day through September 9.

Vote for TTP
GMATLiveTeach 7 seats left
Chris Peckover
NEXT LIVE COHORT

Oct 13 to Jan 7, 2027

with Chris Peckover

Schedule
Tue, Thu · 8:00 to 10:00 PM ET
Included
40 live hours + 6 months of GMAT OnDemand
  • Live instruction and real-time questions
  • Class recordings and assigned practice
View class & enroll
Limited cohort · enrollment openTarget Test Prep
EALiveTeach 5 seats left
Logan Thompson
EXECUTIVE ASSESSMENT

Sep 6 to Dec 6, 2026

with Logan Thompson

Schedule
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll
Limited cohort · enrollment openTarget Test Prep
GMATOnDemand Start anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Compare the format, schedule, and included access before enrolling. Prices and seat counts shown reflect the supplied offer details.

Prescription drugs-GPREP1

Expert replies
Source: — Critical Reasoning |

by medea66 » Thu Aug 21, 2008 5:47 pm
please help!
Join the discussion

by kuroneko1313 » Fri Aug 22, 2008 10:46 am
I think it's A. The expenditure is referring to the resident in my opinion.
Join the discussion

by Suyog » Fri Aug 22, 2008 11:40 am
1. per capita expenditure on prescription drug increased by 15% or more anually.

2. ministry prohibited the manufacturers to increase the price. (price freeze)

Conclusion: still per capita expenditure on prescription drug increased.

2 says... population increased... but still if the population is increased.. they are buying the same drug... (constant price)
this doesnt prove that per capita expenditure on prescription drug increase by substantial %

but if manufacturers produce a new drug replacing existing drug then per capita expenditure on prescription drug will surely increase....
Join the discussion

by 4meonly » Sat Aug 23, 2008 1:11 am
Hope this will help:

By replacing old medications with new medication you can register high price from the beginning and not to increase it further. Also you can eliminate old medicines (they are usually cheaper) mking the whole treatment more costly
Join the discussion

by medea66 » Sat Aug 23, 2008 4:55 pm
So if the old medicine is replaced with new medicine, how is it possible to jack up the price on the new medication if there is a price freeze?
Join the discussion

by banker1 » Tue Aug 26, 2008 10:06 am
medea66 wrote:So if the old medicine is replaced with new medicine, how is it possible to jack up the price on the new medication if there is a price freeze?
The new medicine comes to market at a higher price to begin with. The manufacturer can stop producing the old medicine and force consumers to buy the new, more expensive medice.

HTH
Join the discussion

by jessica.ng1988 » Thu Sep 04, 2008 8:37 am
your choice weakens the argument rather than strengthen it.

in all choices,
only A support. A expresses that resident expenditure on drug still rise because of changed medication from drug manufacturers.
rest out of scope.
Join the discussion

by peter.p.81 » Wed May 11, 2016 2:24 am
Well I feel A is the answer. I guess I'm right. If some expert could
Join the discussion